Ikonisys Closes $30 Million Venture Round
New Haven, CT, diagnostics developer Ikonisys raised $30 million in Series E financing.
New Haven, CT, diagnostics developer Ikonisys raised $30 million in Series E financing.
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Eurofins Discovery
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson
